|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's Range||123.25 - 125.99|
|52 Week Range||73.02 - 131.81|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||15.29|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||2.24 (1.79%)|
|Ex-Dividend Date||Jan 19, 2021|
|1y Target Est||141.81|
Quest Diagnostics (DGX) is moving ahead in terms of its growth strategy, which consists of five elements.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2020 Workplace Health Achievement Index, ranking the company's workplace health initiative among the best in the nation. 2020 marks the third year in a row that Quest has earned this distinction, which comes on the heels of recognitions for the company's HealthyQuest employee population health program, including the C. Everett Koop and National Business Group on Health awards.
Quest Diagnostics saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before.